Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
Meta Platforms
META
Adobe
ADBE
US Stock MarketDetailed Quotes
ASND Ascendis Pharma A/S
- 137.500
- -2.810-2.00%
Close Dec 27 16:00 ET
- 137.500
- 0.0000.00%
Post 20:01 ET
8.22BMarket Cap-17.68P/E (TTM)
141.250High137.260Low164.62KVolume139.390Open140.310Pre Close22.75MTurnover0.28%Turnover RatioLossP/E (Static)59.80MShares161.00052wk High-81.07P/B8.16BFloat Cap111.09052wk Low--Dividend TTM59.36MShs Float183.980Historical High--Div YieldTTM2.84%Amplitude11.920Historical Low138.224Avg Price1Lot Size
Ascendis Pharma A/S Key Stats
EPS
According to the latest financial report of Ascendis Pharma A/S, the latest earnings per share (TTM) for the company is -1.72. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: EUR
Quarterly
Loading...
FCF
Interested in knowing about Ascendis Pharma A/S's free cash flow? The latest report shows it as -101.78M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: EUR
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Ascendis Pharma A/S shows that the company's current ratio is 1.16, indicating healthy liquidity.
Currency: EUR
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Ascendis Pharma A/S, the quick ratio is 0.81, indicating that the company can meet its short-term debt obligations.
Currency: EUR
Quarterly
Loading...
ROE
Want to learn more about the financial health of Ascendis Pharma A/S? The latest ROE figure is -104.66%, indicating that the company has stable profitability.
Currency: EUR
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Ascendis Pharma A/S, the total asset return on investment (ROA) is -10.71%.
Currency: EUR
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Ascendis Pharma A/S's latest financial report to see how their gross margin is doing - currently at 80.63%.
Currency: EUR
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Ascendis Pharma A/S, the net profit margin is -171.52%, which is a good sign for its profitability.
Currency: EUR
Quarterly
Loading...
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.